Stericycle, Inc. is an industry leading multinational business-to-business services provider with a focus on regulated and compliance solutions in the areas of medical, pharmaceutical, hazardous waste and secure information destruction with revenues of $4 billion and operating in 20+ countries as a culmination of 500+ acquisitions.Beginning in 2017, Rich joined Stericycle, Inc. as Senior VP and Chief Accounting Officer. Rich advanced the functional alignment of finance and accounting and continues to lead the team towards the future Target Operating Model. Rich’s scope is to lead corporate accounting, consolidations, tax, financial reporting, technical and internal controls functions, field accounting and related shared services to best-in-class public company standards through the development of people, processes and technology. He led the organization through an internal control transformation to remediate a multi-year pervasive material weaknesses situation. He has also assumed a leadership role in the development of the company’s future Enterprise Performance Management and Enterprise Resource Planning systems. He introduced Global Business Services (end-to-end shared service concepts) to the company and has commenced the transition. Leading 10+ direct reports and a 500+ member global team in 20+ operational countries, he is committed to driving integrity, accuracy, transparency, accountability and continuous improvement.

Independent Advisor for Cushman & WakefieldCushman & Wakefield is a rapidly growing commercial-real-estate-services firm backed by private-equity giant TPG. Serving as a Finance and Accounting Advisor supporting on various initiatives in leadership, project management and execution capacities. Involvement with new system implementations for revenue and commission expense (Salesforce, Workday and Callidus), evolving management reporting inclusive of analytical reviews of standard statements, maturing the accounting close processes, developing an accounting policies harmonization plan, supporting the transition to shared services and completing account reconciliations for the most material and significant accounts.

Hospira, now a Pfizer company, is the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars all of which Hospira develops, manufactures, markets and distributes. Pfizer acquired Hospira in 2015. Hospira has revenues of $5 billion, assets of $7 billion, manufactures product in 15 facilities throughout the world and distributes products globally through an extensive network of company owned operations and independent third-party distributors.Hospira’s business first began operation as part of Abbott Laboratories (Abbott) in the 1930s. As part of a plan to spin off its core hospital products business, Abbott transferred the assets and liabilities relating to Hospira thereby creating Hospira as an independent public company in 2004.In 2015, Hospira entered into an Agreement and Plan of Merger with Pfizer whereby the outstanding shares of Hospira’s common stock were converted into the right to receive $90.00 in cash per share ($17 billion purchase price). Hospira is now a part of Pfizer’s Global Established Products (GEP) business.From 2010 to 2016, Rich served as Corporate VP, Controller & Chief Accounting Officer for Hospira (acquired in 2015), $5B & 15 global manufacturing facilities. He joined Hospira in 2007 as VP, Corporate Controller & Chief Accounting Officer.Leading a 500+ member team, he oversaw global corporate control/reporting functions. As a Finance Leadership Team Member, he facilitated creation of the finance/accounting strategic vision. Execution of the strategy helped achieve annual top-line growth in high single digits, operating margin improvement in mid-teens and substantial operating cash flow improvements. He implemented business performance improvements/process reengineering initiatives that realized savings, efficiencies, & improved business understanding/partnering.

CNH Global N.V. (CNH, now known as CNH Industrial with incremental operations) was a global, full-line company in both the agricultural and construction equipment industries, with strong positions in most significant geographic and product categories. CNH’s global scope and scale included integrated engineering, manufacturing, marketing and distribution of equipment on five continents and organized operations into three business segments: agricultural equipment, construction equipment and financial services. CNH had revenues of $13 billion, assets of $18 billion, manufactured product in 39 facilities throughout the world and distributed product in approximately 160 countries through an extensive network of approximately 11,500 dealers and distributors. CNH combined the operations of New Holland N.V. and Case Corporation as a result of their business merger in 1999.Previously, Rich held leadership positions with CNH Global NV. As VP, Corporate Controller & Chief Accounting Officer, he led a 700+ member global team; maintained consolidated records under US GAAP and IFRS; enhanced compliance, controls, governance/efficiencies and reduced costs.

Assurance and Advisory ServicesProvided accounting and business advisory services to privately/publicly held multi-national businesses ranging from $20M to $20B in revenue (including financial audits, implementation of new accounting standards, SEC reporting, acquisition due diligence, control reviews, initial public offering, equity and debt transactions, business plans, forecasts and operational reviews). Lead audit senior manager on Deere & Company (John Deere) engagement for 3+ years.